These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8849382

  • 21. [Analytic study of dot blotting for the detection of anti-Jo-1, anti-M2, anti-ribosomes and anti-LKM].
    Huguet S, Sghiri R, Ballot E, Johanet C.
    Ann Biol Clin (Paris); 2004; 62(4):423-9. PubMed ID: 15297236
    [Abstract] [Full Text] [Related]

  • 22. Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
    Herbert MK, Stammen-Vogelzangs J, Verbeek MM, Rietveld A, Lundberg IE, Chinoy H, Lamb JA, Cooper RG, Roberts M, Badrising UA, De Bleecker JL, Machado PM, Hanna MG, Plestilova L, Vencovsky J, van Engelen BG, Pruijn GJ.
    Ann Rheum Dis; 2016 Apr; 75(4):696-701. PubMed ID: 25714931
    [Abstract] [Full Text] [Related]

  • 23. [Cloning and prokaryotic expression of recombinant Jo-1 antigen and identification of its antigen specificity].
    Zhao XY, Bi ZL, Wu YH, Xin HT.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1170-3. PubMed ID: 19068203
    [Abstract] [Full Text] [Related]

  • 24. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 25. Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies.
    Nagashima T, Sato H, Minota S.
    J Rheumatol; 2009 Sep; 36(9):2133-4. PubMed ID: 19738232
    [No Abstract] [Full Text] [Related]

  • 26. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease.
    Targoff IN, Trieu EP, Plotz PH, Miller FW.
    Arthritis Rheum; 1992 Jul; 35(7):821-30. PubMed ID: 1622421
    [Abstract] [Full Text] [Related]

  • 27. [The anti-synthetase syndrome].
    Bergoin C, Bure M, Tavernier JY, Lamblin C, Maurage CA, Remy-Jardin M, Wallaert B.
    Rev Mal Respir; 2002 Jun; 19(3):371-4. PubMed ID: 12161705
    [Abstract] [Full Text] [Related]

  • 28. Immunoserological aspects of idiopathic inflammatory muscle disease.
    Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):722-7. PubMed ID: 11020964
    [Abstract] [Full Text] [Related]

  • 29. Anti-Jo-1 autoantibodies and the immunopathogenesis of autoimmune myositis.
    Tsui FW, Siminovitch KA.
    Int Rev Immunol; 1991 Aug 25; 7(3):225-35. PubMed ID: 1721933
    [Abstract] [Full Text] [Related]

  • 30. [Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].
    Katsuki Y, Hirakata M.
    Nihon Rinsho; 2005 Jul 25; 63 Suppl 7():505-7. PubMed ID: 16111315
    [No Abstract] [Full Text] [Related]

  • 31. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep 25; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 32. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J, Chatelus E, Meyer A, Gottenberg JE, Sordet C, Goetz J.
    Presse Med; 2010 Oct 25; 39(10):1010-25. PubMed ID: 20655695
    [Abstract] [Full Text] [Related]

  • 33. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A.
    J Immunol Methods; 2012 Oct 31; 384(1-2):128-34. PubMed ID: 22884621
    [Abstract] [Full Text] [Related]

  • 34. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M.
    J Rheumatol; 1984 Oct 31; 11(5):663-5. PubMed ID: 6334746
    [Abstract] [Full Text] [Related]

  • 35. Clinical and histological features of 'mechanic's hands' in a patient with antibodies to Jo-1--a case report.
    Mitra D, Lovell CL, Macleod TI, Tan RS, Maddison PJ.
    Clin Exp Dermatol; 1994 Mar 31; 19(2):146-8. PubMed ID: 8050145
    [Abstract] [Full Text] [Related]

  • 36. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].
    Xie MM, Yan X, Li H, Ding JJ, Gui XH, Liu Y, Wang YS, Chen ZY, Cai HR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug 12; 41(8):616-621. PubMed ID: 30138971
    [Abstract] [Full Text] [Related]

  • 37. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients.
    Váncsa A, Gergely L, Ponyi A, Lakos G, Németh J, Szodoray P, Dankó K.
    Joint Bone Spine; 2010 Mar 12; 77(2):125-30. PubMed ID: 20188618
    [Abstract] [Full Text] [Related]

  • 38. Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies.
    Sato S, Hirakata M, Kuwana M, Nakamura K, Suwa A, Inada S, Mimori T, Ikeda Y.
    Clin Exp Rheumatol; 2005 Mar 12; 23(5):609-15. PubMed ID: 16173235
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.